2.4 should be bottom. This is where the CR should be done if we have one before the deal IMO, going off the last one.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025